Tumor-Associated Circulating MicroRNAs as Biomarkers of Cancer
MicroRNAs (miRNAs), the 17- to 25-nucleotide long noncoding RNAs that modulate the expression of mRNAs and proteins, have emerged as critical players in cancer initiation and progression processes. Deregulation of tissue miRNA expression levels associated with specific genetic alterations has been d...
Main Authors: | Jin Wang, Ke-Yong Zhang, Song-Mei Liu, Subrata Sen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2014-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/19/2/1912 |
Similar Items
-
<i>PlasmiR</i>: A Manual Collection of Circulating microRNAs of Prognostic and Diagnostic Value
by: Spyros Tastsoglou, et al.
Published: (2021-07-01) -
Circulating MicroRNAs and Long Non-coding RNAs as Potential Diagnostic Biomarkers for Parkinson’s Disease
by: Yimin Yang, et al.
Published: (2021-03-01) -
Circulating MicroRNAs as Biomarkers for Sepsis
by: Fabian Benz, et al.
Published: (2016-01-01) -
Circulating Exosome microRNAs as Diagnostic Biomarkers of Dementia
by: Xiaoyu Dong, et al.
Published: (2020-09-01) -
Circulating microRNAs: Promising candidates serving as novel biomarkers of acute hepatitis
by: Natalia eElfimova, et al.
Published: (2012-12-01)